Synopsis Gastric cancer (GC) is one of five leading causes of deaths worldwide, with an overall survival rate of 25-30%. The present long-term follow-up study quantifies the Gastric Cancer risk associated with each Operative Link for Gastritis Assessment (OLGA) stage. This week’s “ MED FACT ” discusses a clinical trial from The American Journal of Gastroenterology, “OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients.” Oct 2018 Authors: Massimo Rugge et. al.
Key Takeaways Gastritis staging is a key aide in endoscopy follow-up protocols intended to prevent GC. Objective: Gastritis OLGA staging ranks the risk for gastric cancer in progressive stages (0–IV) Study Type: Long-term follow-up study Participants: 7436 What Was The Need For This Study? Based on histological staging the risk of GC is ranked in progressive staging. The…
